Home LiteratureArticle Details
PMID: 21438170 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Longitudinal measures of lung function in infants with bronchopulmonary dysplasia.

Pediatric pulmonology ·Vol. 46 ·No. 4 ·2011-04-00 ·Pages 369-75

Filbrun AG, Popova AP, Linn MJ, McIntosh NA, Hershenson MB

Abstract

We previously demonstrated that infants with a history of bronchopulmonary dysplasia (BPD) exhibit airflow obstruction and air trapping. The purpose of this study was to assess longitudinal changes in pulmonary function in infants with a history of BPD over the first 3 years of life, and the relationship to somatic growth. Spirometry was measured using the raised volume rapid thoracoabdominal compression technique, and lung volumes measured by plethysmography. Eighteen infants (mean gestational age ± SD 27.3 ± 2.2 weeks, birthweight 971 ± 259 g) underwent two lung function studies. Average age at first test was 58.8 weeks. Spirometry demonstrated significant reductions in forced expiratory volume in 0.5 sec (FEV(0.5), 76.0 ± 15.9% predicted, Z-score -2.13 ± 1.69), forced expiratory flow at 75% of expired forced vital capacity (FEF(75), 54.8 ± 31.1%, -3.58 ± 2.73), and FEF(25-75) (67.8 ± 33.3%, -1.79 ± 1.76). Group mean total lung capacity (TLC) was in the low normal range (82.9 ± 13.5% predicted) and residual volume (RV)/TLC was mildly elevated (122.4 ± 38.2% predicted). Repeat testing was performed an average of 32.7 weeks after initial testing. At re-evaluation, group mean lung volumes and flows tracked at or near their previous values; thus, in general, there was a lack of catch-up growth. However, compared to infants with below average or average somatic growth (as represented by g/day), infants with above average growth showed significantly greater improvements in percent predicted FVC, FEV(0.5), TLC, and RV/TLC (all P < 0.05, ANOVA). We conclude that longitudinal measures of pulmonary function in infants and young children with BPD demonstrate significant airflow obstruction and modest restriction, which tends to persist with time. On the other hand, infants with above average somatic growth showed greater lung growth than their peers. Additional studies examining the effects of various nutritional regimens on lung function are warranted.

MeSH Terms
Bronchopulmonary Dysplasia/diagnosis,physiopathology Child, Preschool Female Humans Infant Infant, Newborn Longitudinal Studies Lung/physiopathology Male Respiratory Function Tests
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Filbrun Amy G
Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan 48109-0212, USA. [email protected]
Popova Antonia P
Linn Marisa J
McIntosh Nancy A
Hershenson Marc B
References (33)
33 references, click to expand
  1. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
    Circulation. 2005 Oct 18;112(16):2477-86 PMID: 16230500
  2. Assessment of pulmonary function in resolving chronic lung disease of prematurity.
    Arch Dis Child Fetal Neonatal Ed. 1997 Mar;76(2):F113-7 PMID: 9135290
  3. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.
    Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1971-80 PMID: 11734454
  4. Expiratory flow limitation in infants with bronchopulmonary dysplasia.
    J Pediatr. 1986 Dec;109(6):1040-6 PMID: 3783328
  5. Small size at birth and greater postnatal weight gain: relationships to diminished infant lung function.
    Am J Respir Crit Care Med. 2004 Sep 1;170(5):534-40 PMID: 15172897
  6. Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity.
    Acta Paediatr. 2000 Nov;89(11):1375-80 PMID: 11106053
  7. Abnormal lung function in healthy preterm infants.
    Am J Respir Crit Care Med. 2002 Jan 1;165(1):83-7 PMID: 11779735
  8. Pulmonary function in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2004 Mar;37(3):236-42 PMID: 14966817
  9. Worsening of V'maxFRC in infants with chronic lung disease in the first year of life: a more favorable outcome after high-frequency oscillation ventilation.
    Am J Respir Crit Care Med. 2002 Dec 15;166(12 Pt 1):1539-43 PMID: 12471071
  10. Trends in neonatal morbidity and mortality for very low birthweight infants.
    Am J Obstet Gynecol. 2007 Feb;196(2):147.e1-8 PMID: 17306659
  11. IL-1beta disrupts postnatal lung morphogenesis in the mouse.
    Am J Respir Cell Mol Biol. 2007 Jan;36(1):32-42 PMID: 16888287
  12. Dynamic maintenance of end-expiratory lung volume in full-term infants.
    J Appl Physiol Respir Environ Exerc Physiol. 1984 Oct;57(4):1126-33 PMID: 6501029
  13. Serial determination of pulmonary function in infants with chronic lung disease.
    J Pediatr. 1987 Mar;110(3):448-56 PMID: 3819948
  14. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992.
    Pediatr Pulmonol. 2006 Jun;41(6):570-6 PMID: 16617453
  15. Forced expiratory flows and volumes in infants. Normative data and lung growth.
    Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):353-9 PMID: 10673171
  16. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia?
    Am J Respir Cell Mol Biol. 2004 Dec;31(6):650-6 PMID: 15333328
  17. Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study.
    Pediatr Pulmonol. 1997 Jul;24(1):22-8 PMID: 9261849
  18. The new BPD: an arrest of lung development.
    Pediatr Res. 1999 Dec;46(6):641-3 PMID: 10590017
  19. Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia.
    Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1068-78 PMID: 16829629
  20. Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis.
    Pediatr Pulmonol. 2001 Sep;32(3):201-10 PMID: 11536449
  21. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Semin Perinatol. 2006 Aug;30(4):200-8 PMID: 16860160
  22. Adult-type pulmonary function tests in infants without respiratory disease.
    Pediatr Pulmonol. 2000 Sep;30(3):215-27 PMID: 10973040
  23. Bronchopulmonary dysplasia.
    Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9 PMID: 11401896
  24. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells.
    Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L735-43 PMID: 20190033
  25. Reduced lung function in healthy preterm infants in the first months of life.
    Am J Respir Crit Care Med. 2006 Feb 15;173(4):442-7 PMID: 16322648
  26. Longitudinal changes in lung function during the first three years of premature infants with moderate to severe bronchopulmonary dysplasia.
    Pediatr Pulmonol. 1991;11(1):8-14 PMID: 1923670
  27. Airway dimensions in bronchopulmonary dysplasia: implications for airflow obstruction.
    Pediatr Pulmonol. 2008 Dec;43(12):1206-13 PMID: 18991341
  28. Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in preschool children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2006 Jun;41(6):538-43 PMID: 16617449
  29. Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes.
    J Appl Physiol (1985). 1996 Jun;80(6):2019-25 PMID: 8806909
  30. Obstructive lung disease in children with mild to severe BPD.
    Respir Med. 2010 Mar;104(3):362-70 PMID: 19906521
  31. Bronchodilator responsiveness in normal infants and young children.
    Am J Respir Crit Care Med. 2001 Aug 1;164(3):447-54 PMID: 11500348
  32. Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood.
    Pediatr Res. 2006 Sep;60(3):340-4 PMID: 16857773
  33. Interleukin (IL)-1 beta in tracheal aspirates from premature infants induces airway epithelial cell IL-8 expression via an NF-kappa B dependent pathway.
    Pediatr Res. 2004 Dec;56(6):907-13 PMID: 15496610
Article Info
Journal
Pediatric pulmonology
Abbr.
Pediatr Pulmonol
ISSN
1099-0496
Published
2011-04-00
Epub
2010-00-17
Pages
369-75
Language
English
Region
United States
NLM ID
8510590
PMCID
PMC3801101
Subset
IM
Grants
NHLBI NIH HHS · R01 HL090134 · United States
NHLBI NIH HHS · HL90134 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]